(2003) 170:4905–13. doi:10.4049/jimmunol.170.10.4905 94. MiyazawaM,KatsudaM, MaguchiH, Katanuma A,IshiiH, OzakaM ,et al. Phase II clinical trial using novel peptide cocktail vaccine as a postoperativeadjuvant treatment for surgically resected pancreatic cancer patie nts.Int J Cancer.(2017)140:973–82.doi:10.1002/ijc.30510 95. Mayanagi S, Kitago M, Sakurai T, Matsuda T, Fujita T, Higuch i H, et al. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Cancer Sci.